e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Lung development and neoplasia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diverse effects of PAI-1 proteins on lung and prostate cancer cell invasion
A. Rozy, M. Kedzior, J. Chorostowska-Wynimko, P. Jagus, A. Szpechcinski, E. Skrzypczak-Jankun, J. Jankun (Warsaw, Poland; Toledo, United States Of America)
Source:
Annual Congress 2011 - Lung development and neoplasia
Session:
Lung development and neoplasia
Session type:
Thematic Poster Session
Number:
3816
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Rozy, M. Kedzior, J. Chorostowska-Wynimko, P. Jagus, A. Szpechcinski, E. Skrzypczak-Jankun, J. Jankun (Warsaw, Poland; Toledo, United States Of America). Diverse effects of PAI-1 proteins on lung and prostate cancer cell invasion. Eur Respir J 2011; 38: Suppl. 55, 3816
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Influence of overexpression of coagulantic and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007
Expression of βig-h3 as a marker of local tumor invasion in non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 770s
Year: 2006
Adenylate cyclase-associated protein 1 is associated with metastasis of non-small cell lung cancer especially in brain metastasis patients and promotes the lung cancer cell proliferation and migration in vitro as well as its growth and metastasis in vivo by the signaling pathways of limk1-cofilin
Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours
Year: 2015
Bile acid receptor mediates cancer-associated fibroblasts-induced migration and invasion of non-small cell lung cancer cells
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017
Prognostic and potential therapeutic impact of prostate specific membrane antigen expression in non-small cell lung cancer
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
Are there any peculiarities in tumour behavior and different tumour markers expression in nonsmall cell lung cancer?
Source: Eur Respir J 2001; 18: Suppl. 33, 232s
Year: 2001
Over-expression of aquaporin-5 increases migration and metastatic potential of lung cancer cells
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009
Expression of ERCC1 in normal and tumor tissues in non-small cell lung cancer
Source: Annual Congress 2007 - Biology of thoracic malignancies
Year: 2007
Importance of clusterin expression at tissue level for the prognosis of non-small cells lung cancer
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009
CHD4 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor cell proliferation
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
The influence of brown adipose tissue on the proliferation and chemosensitivity in non-small cell lung cancer cells
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018
The impact of thrombosis events in excised tumor tissues on the prognosis of non-small cell lung cancer
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
IRP2 as a potential modulator of cell proliferation, apoptosis and prognosis in nonsmall cell lung cancer
Source: Eur Respir J , 49 (4) 1600711; DOI: 10.1183/13993003.00711-2016
Year: 2017
Adipocyte-derived exosomes promote lung cancer metastasis byincreasing MMP9 activity via transferring MMP3 to lung cancer cells
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017
Proapoptotic effects of PAI-1 protein on lung and prostate cancer cells
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
Prognostic value of non-angiogenic and angiogenic growth patterns in non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 40s
Year: 2004
Proteinase inhibition regulates the anti-tumor activity of PAI-1 towards lung and prostate cancer cells
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011
Breast metastasis in association with non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 538s
Year: 2005
Survivin expression in non-small cell lung cancer
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
HIF-1α modulation by topoisomerase inhibitors in A549, a non-small cell lung cancer cell line
Source: Annual Congress 2007 - Biology in thoracic oncology
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept